Head of Business Continuity & Resilience

Company: Alexion Pharma Spain S.L.
Location: New Haven
Posted on: September 12, 2020

Job Description:

Head of Business Continuity & Resilience Attention: If you are a current Alexion employee, please apply via

Alexion’s internal Life & Career portal . Note that you will need to be connected to the VPN if you are applying away from the office.

Alexion does not contact candidates via instant messaging or chat tools. At no time will we ask candidates for fees associated with obtaining software, nor do we provide employees with a cashier’s check to purchase new equipment. If you are contacted in this manner, please be aware that it is fraudulent, and please do not provide any information or money to these individuals. Applicants should only apply through this Alexion website. Any fraudulent activity should be reported to GSOC@alexion.com

Share this job We are agnostic to the location for this position

Position Summary

Alexion is seeking a Head of Business Continuity & Resilience to lead our Business Continuity and Disaster Recovery Program. The candidate will lead the design, development, execution and maintenance of business impact assessments, business continuity plans, and disaster recovery plans for operational resilience across the enterprise to ensure Alexion’s ability to deliver life-changing therapies to our patients. The purpose of this role is to ensure critical business processes remain available during a disruption.

Job Duties & Responsibilities

Define, develop, and execute on Alexion’s Operational Resilience Program goals

Develop plans, policies, and implement strategies to mitigate the impact of potential adverse conditions such as natural disasters, acts of terror/war, cyberattacks, epidemics/pandemics, etc. on company operations

Partner with Crisis Management & Incident Management teams to ensure critical processes maintain continuity during disruptions.

Work with a wide range of business teams to conduct business impact assessments, identify critical services, define recovery objectives, and map critical dependencies.

Work with business teams to develop strategies and proposals for mitigating business continuity risks

Monitor and determine impact on recovery strategies and determine need for convening and or activation of response teams during a business disruption based on severity levels or other escalation triggers.

Facilitate recovery efforts during a disaster

Facilitate business impact analysis and risk assessments to determine potential effects of an interruption to operations

Ensure proper development of business continuity plans, procedures and associated roles needed to recover critical business functions

Provide guidance for disaster recovery and oversee infrastructure deployment according to a business impact and risk-based approach

Lead validation, maintenance and testing of plans through training and exercises with increasing degrees of complexity

Write after action reports for incidents and exercises; Track open action items to completion

Implement effective tracking of program deliverables based on established KPIs

Preferred Qualifications

Minimum of 10 years of experience leading Operation Resilience and Disaster Recovery programs

Experience with Fusion Framework System, Balbix, and Sungard

Proven ability to work in a global environment with various levels of maturity

Ability to collaborate and influence stakeholders

Candidates must have ability to communicate at executive level, both written and orally, through superior communication skills

Ability to prioritize projects and strong problem-solving skills

Experience working with decision making, multi-tasking, and high stress situations

Experience in the biotech/biopharmaceutical industry

Understanding of Project Management methodologies preferred

Education

DRI Certified Business Continuity Professional (CBCP) preferred

*LI-DD1

Some opportunities happen only once in a lifetime – like a job where you have the extraordinary opportunity to change lives. At Alexion, such opportunities arise through our unwavering mission to serve patients and families affected by rare diseases. These patients are our guiding star, and we act with integrity, urgency, and discipline because we know their lives are at stake.

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies. As the global leader in complement biology and inhibition for more than 20 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) as well as the first and only approved complement inhibitor to treat atypical hemolytic uremic syndrome (aHUS), anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D). In addition, the company is developing several mid-to-late-stage therapies, including a second complement inhibitor, a copper-binding agent for Wilson disease and an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases as well as several early-stage therapies, including one for light chain (AL) amyloidosis and a second anti-FcRn therapy. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, and metabolic disorders. Alexion has been named to the Forbes’ list of the World’s Most Innovative Companies seven years in a row and is headquartered in Boston, Massachusetts’ Innovation District. The company also has offices around the globe and serves patients in more than 50 countries. Further information about Alexion can be found at: www.alexion.com.

As a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more.

Alexion participates in E-Verify process. To learn more, please click on attached document(s)

Keywords: Alexion Pharma Spain S.L., New Haven , Head of Business Continuity & Resilience, Other , New Haven, Connecticut